Amphastar Pharmaceuticals AMPH Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $170.18M+12.2% | $151.61M+5.1% | $144.3M-7.6% | $156.1M+23.5% | ||
| $112.64M+60.8% | $70.04M-37.8% | $112.51M+472% | $19.66M+90.5% | ||
| $143.56M+5.3% | $136.29M+18.6% | $114.94M+29.4% | $88.8M+12.7% | ||
| $176.89M+15.1% | $153.74M+45.3% | $105.83M+2.2% | $103.58M+11.6% | ||
| $636.02M+19.1% | $534.07M+9.1% | $489.6M+29.4% | $378.32M+18.9% | ||
| $310.57M+4.4% | $297.35M+5.2% | $282.75M+18.7% | $238.27M-2.4% | ||
| $565.97M-4.2% | $590.66M-3.7% | $613.3M+1,544% | $37.3M-4.0% | ||
| $1.63B+3.3% | $1.58B+4.3% | $1.51B+104% | $741.99M+10.5% | ||
| $148.35M-5.5% | $157.06M+68.2% | $93.37M+10.8% | $84.24M-5.9% | ||
| $1.64M+601% | $234K-46.3% | $436K-85.7% | $3.05M+38.3% | ||
| $158.16M-9.0% | $173.76M-22.9% | $225.41M+138% | $94.86M-8.6% | ||
| $608.75M+1.2% | $601.63M+2.0% | $589.58M+709% | $72.84M-2.6% | ||
| $840.49M-0.6% | $845.17M-3.2% | $873.49M+309% | $213.33M-5.6% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| $666.88M+17.2% | $568.79M+39.0% | $409.27M+50.6% | $271.72M+50.7% | ||
| $1.63B+3.3% | $1.58B+4.3% | $1.51B+104% | $741.99M+10.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Amphastar Pharmaceuticals's total assets?
- Amphastar Pharmaceuticals (AMPH) holds $1.6B in total assets, up 1.4% year over year.
- How much cash does Amphastar Pharmaceuticals have?
- Amphastar Pharmaceuticals holds $170.9M in cash and equivalents.
- Can Amphastar Pharmaceuticals cover its short-term obligations?
- Its current ratio is 3.85 — current assets exceed current liabilities.
- Where does Amphastar Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
